EV
Eric Venker sold $120K of IMVT stock
Eric Venker, Chief Executive Officer of Immunovant, Inc. (IMVT), sold 3,506 shares of IMVT stock worth $120K, per an SEC Form 4 filed Oct 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 1, 2026, 4 days before it was made public.
IMVT has moved +1.6% since the trade date, from $33.65 to $34.18 (Nov 13, 2026 close).
- Traded
- Oct 1, 2026
- Disclosed
- Oct 5, 2026
- Filing delay
- 4 days
- Price since
- +1.6%
- Role
- Chief Executive Officer
- Source
- SEC Form 4